North America Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity

December 2021 | 103 pages | ID: N879B6707E3DEN
GMD Research

Abstracts

North America genome sequencing market is projected to grow by 11.5% annually in the forecast period and reach $10.77 billion by 2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.

Highlighted with 23 tables and 49 figures, this 103-page report “North America Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America genome sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Consumables
• Sequencers & Software
• Service

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Polymerase Chain Reaction (PCR)
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Other Technologies

Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Diagnostics
• Oncology
• Reproductive Health
• Complex Disease Research
• Other Diagnostics
• Drug Discovery and Development
• Precision Medicine
• Agriculture and Animal Research
• Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Academic & Research Centers
• Pharmaceutical and Biotechnology Companies
• Consumer Genomic Service Providers
• Government Institutes
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

BGI

Biomatters

Bio-Rad Laboratories, Inc.

DNASTAR

F. Hoffmann-La Roche

Illumina, Inc.

Macrogen Inc.

Myriad Genetics, Inc.

New England Biolabs

Oxford Nanopore Technology

PerkinElmer Inc.

Qiagen

Siemens Healthineers

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT

3.1 Market Overview by Product
3.2 Consumables
3.3 Sequencers & Software
3.4 Service

4 SEGMENTATION OF NORTH AMERICA MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Polymerase Chain Reaction (PCR)
4.3 Sequencing
4.4 Microarray
4.5 Nucleic Acid Extraction and Purification
4.6 Other Technologies

5 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Diagnostics
  5.2.1 Oncology
  5.2.2 Reproductive Health
  5.2.3 Complex Disease Research
  5.2.4 Other Diagnostics
5.3 Drug Discovery and Development
5.4 Precision Medicine
5.5 Agriculture and Animal Research
5.6 Other Applications

6 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

6.1 Market Overview by End User
6.2 Academic & Research Centers
6.3 Pharmaceutical and Biotechnology Companies
6.4 Consumer Genomic Service Providers
6.5 Government Institutes
6.6 Other End Users

7 NORTH AMERICA MARKET 2019-2030 BY COUNTRY

7.1 Overview of North America Market
7.2 U.S.
7.3 Canada
7.4 Mexico

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
BGI
Biomatters
Bio-Rad Laboratories, Inc.
DNASTAR
F. Hoffmann-La Roche
Illumina, Inc.
Macrogen Inc.
Myriad Genetics, Inc.
New England Biolabs
Oxford Nanopore Technology
PerkinElmer Inc.
Qiagen
Siemens Healthineers
Thermo Fisher Scientific
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of North America Genome Sequencing Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. World Health Spending by Region, $ bn, 2013-2020
Table 4. Main Product Trends and Market Opportunities in North America Genome Sequencing Market
Table 5. North America Genome Sequencing Market by Product, 2019-2030, $ mn
Table 6. North America Genome Sequencing Market by Technology, 2019-2030, $ mn
Table 7. North America Genome Sequencing Market by Application, 2019-2030, $ mn
Table 8. North America Genome Sequencing Market: Diagnostics by Type, 2019-2030, $ mn
Table 9. North America Genome Sequencing Market by End User, 2019-2030, $ mn
Table 10. North America Genome Sequencing Market by Country, 2019-2030, $ mn
Table 11. U.S. Genome Sequencing Market by Product, 2019-2030, $ mn
Table 12. U.S. Genome Sequencing Market by Application, 2019-2030, $ mn
Table 13. U.S. Genome Sequencing Market by End User, 2019-2030, $ mn
Table 14. Canada Genome Sequencing Market by Product, 2019-2030, $ mn
Table 15. Canada Genome Sequencing Market by Application, 2019-2030, $ mn
Table 16. Canada Genome Sequencing Market by End User, 2019-2030, $ mn
Table 17. Mexico Genome Sequencing Market by Product, 2019-2030, $ mn
Table 18. Mexico Genome Sequencing Market by Application, 2019-2030, $ mn
Table 19. Mexico Genome Sequencing Market by End User, 2019-2030, $ mn
Table 20. BGI: Company Snapshot
Table 21. BGI: Business Segmentation
Table 22. BGI: Product Portfolio
Table 23. BGI: Revenue, 2018-2020, $ mn

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 4. North America Genome Sequencing Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Genome Sequencing Market
Figure 7. World Number of Deaths by Cause in 2017
Figure 8. World Number of Deaths from Cancers in 2017
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of North America Genome Sequencing Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of North America Genome Sequencing Market
Figure 14. Breakdown of North America Genome Sequencing Market by Product, 2019-2030, % of Revenue
Figure 15. North America Addressable Market Cap in 2021-2030 by Product, Value ($ mn) and Share (%)
Figure 16. North America Genome Sequencing Market by Product: Consumables, 2019-2030, $ mn
Figure 17. North America Genome Sequencing Market by Product: Sequencers & Software, 2019-2030, $ mn
Figure 18. North America Genome Sequencing Market by Product: Service, 2019-2030, $ mn
Figure 19. Breakdown of North America Genome Sequencing Market by Technology, 2019-2030, % of Sales Revenue
Figure 20. North America Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%)
Figure 21. North America Genome Sequencing Market by Technology: Polymerase Chain Reaction (PCR), 2019-2030, $ mn
Figure 22. North America Genome Sequencing Market by Technology: Sequencing, 2019-2030, $ mn
Figure 23. North America Genome Sequencing Market by Technology: Microarray, 2019-2030, $ mn
Figure 24. North America Genome Sequencing Market by Technology: Nucleic Acid Extraction and Purification, 2019-2030, $ mn
Figure 25. North America Genome Sequencing Market by Technology: Other Technologies, 2019-2030, $ mn
Figure 26. Breakdown of North America Genome Sequencing Market by Application, 2019-2030, % of Sales Revenue
Figure 27. North America Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%)
Figure 28. North America Genome Sequencing Market by Application: Diagnostics, 2019-2030, $ mn
Figure 29. North America Genome Sequencing Market by Diagnostics: Oncology, 2019-2030, $ mn
Figure 30. North America Genome Sequencing Market by Diagnostics: Reproductive Health, 2019-2030, $ mn
Figure 31. North America Genome Sequencing Market by Diagnostics: Complex Disease Research, 2019-2030, $ mn
Figure 32. North America Genome Sequencing Market by Diagnostics: Other Diagnostics, 2019-2030, $ mn
Figure 33. North America Genome Sequencing Market by Application: Drug Discovery and Development, 2019-2030, $ mn
Figure 34. North America Genome Sequencing Market by Application: Precision Medicine, 2019-2030, $ mn
Figure 35. North America Genome Sequencing Market by Application: Agriculture and Animal Research, 2019-2030, $ mn
Figure 36. North America Genome Sequencing Market by Application: Other Applications, 2019-2030, $ mn
Figure 37. Breakdown of North America Genome Sequencing Market by End User, 2019-2030, % of Revenue
Figure 38. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 39. North America Genome Sequencing Market by End User: Academic & Research Centers, 2019-2030, $ mn
Figure 40. North America Genome Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn
Figure 41. North America Genome Sequencing Market by End User: Consumer Genomic Service Providers, 2019-2030, $ mn
Figure 42. North America Genome Sequencing Market by End User: Government Institutes, 2019-2030, $ mn
Figure 43. North America Genome Sequencing Market by End User: Other End Users, 2019-2030, $ mn
Figure 44. Breakdown of North America Genome Sequencing Market by Country, 2019 and 2030, % of Revenue
Figure 45. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 46. U.S. Genome Sequencing Market, 2019-2030, $ mn
Figure 47. Canada Genome Sequencing Market, 2019-2030, $ mn
Figure 48. Genome Sequencing Market in Mexico, 2019-2030, $ mn
Figure 49. Growth Stage of North America Genome Sequencing Industry over the Forecast Period